Alex Nie

Photo of Alex Nie

Dr. Alex Nie is a partner in the Intellectual Property Practice Group in the firm’s Palo Alto office.

Subscribe to all posts by Alex Nie

Federal Circuit Confirms Addition of Two Inventors of Groundbreaking Immunotherapies for Cancer

In Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co. Ltd, the Federal Circuit held that two scientists, Dr. Gordon Freeman and Dr. Clive Wood, should be included as joint inventors, along with Dr. Tasuku Honjo for patents related to immunotherapy for treating cancer. Identifying foundational discoveries underlying a patent claim could be considered a significant … Continue Reading

Machine Learning Patentability in 2019: 5 Cases Analyzed and Lessons Learned Part 5

Introduction This article is the fifth in a five-part series. Each of these articles relates to the state of machine-learning patentability in the United States during 2019. Each of these articles describe one case in which the PTAB reversed an Examiner’s Section-101 rejection of a machine-learning-based patent application’s claims. The first article of this series … Continue Reading

Congress Gives Patent and Trademark Office Temporary Authorization to Move Deadlines in Light of COVID-19 Pandemic

On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security (CARES) Act into law.  The CARES Act is a $2 trillion economic stimulus and rescue package designed to mitigate the economic impact of the COVID-19 global pandemic caused by the novel coronavirus, which has resulted in a level of societal and … Continue Reading

Machine Learning Patentability in 2019: 5 Cases Analyzed and Lessons Learned Part 4

Introduction This article is the fourth in a five-part series. Each of these articles relates to the state of machine-learning patentability in the United States during 2019. Each of these articles describe one case in which the PTAB reversed an Examiner’s Section-101 rejection of a machine-learning-based patent application’s claims. The first article of this series … Continue Reading

Machine Learning Patentability in 2019: 5 Cases Analyzed and Lessons Learned Part 3

Introduction This article is the third in a five-part series. Each of these articles relates to the state of machine-learning patentability in the United States during 2019. Each of these articles describe one case in which the PTAB reversed an Examiner’s Section 101 rejection of a machine-learning-based patent application’s claims. The first article of this … Continue Reading

Machine Learning Patentability in 2019: 5 Cases Analyzed and Lessons Learned Part 2

Introduction This article is the second in a five-part series. Each of these articles relates to the state of machine-learning patentability in the United States during 2019. Each of these articles describe one case in which the PTAB reversed an Examiner’s Section-101 rejection of a machine-learning-based patent application’s claims. The first article of this series … Continue Reading

Machine Learning Patentability in 2019: 5 Cases Analyzed and Lessons Learned Part 1

Introduction This article is the first of a five-part series of articles dealing with what patentability of machine learning looks like in 2019. This article begins the series by describing the USPTO’s 2019 Revised Patent Subject Matter Eligibility Guidance (2019 PEG) in the context of the U.S. patent system. Then, this article – and the … Continue Reading

Federal Circuit Weighs in on Patent Subject-Matter Eligibility of Dietary Supplements

The Federal Circuit weighed in on patent subject matter eligibility again last week, finding certain amino-acid containing dietary supplements, and related methods of use, to be patent eligible. In Natural Alternatives Int’l v. Creative Compounds, LLC, the Federal Circuit vacated the decision of the district court in the Southern District of California, which held that … Continue Reading
LexBlog

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.

Agree